Alumis to Attend Investor Conferences Scheduled for September

Written by Emily J. Thompson, Senior Investment Analyst

Source: Globenewswire

Updated: Aug 28 2025

0mins

Source: Globenewswire

Alumis Inc. Investor Conference Participation

Upcoming Conferences: Alumis Inc. will participate in several investor conferences, including the Cantor Global Healthcare Conference on September 3, Wells Fargo Healthcare Conference on September 5, and the Morgan Stanley Global Healthcare Conference on September 8, among others. Each event will feature fireside chats or presentations at specific times.
Webcast Access: Live webcasts of these events will be available on the "Events" page of the Alumis website, with replays archived for 90 days.

About Alumis Inc.

Company Overview: Alumis is a late-stage biopharma company focused on developing targeted therapies for immune-mediated diseases. The company utilizes a proprietary data analytics platform to enhance patient health outcomes.
Pipeline Development: The company is advancing a pipeline that includes envudeucitinib for systemic immune-mediated disorders, A-005 for neuroinflammatory diseases, and lonigutamab for thyroid eye disease, along with several preclinical programs.

Forward-Looking Statements

Disclaimer: The press release includes forward-looking statements regarding Alumis' conference participation and disclaims any obligation to update these statements unless legally required.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.